Chapter 1: Narcolepsy Therapeutics Market Overview

1.1 Global Market Size of Narcolepsy Therapeutics Market (2021-2033)
1.2 Overview and Scope of Narcolepsy Therapeutics Market
1.3 Classification of Narcolepsy Therapeutics Market by Drug Class
1.3.1 Global Narcolepsy Therapeutics Market Revenue Comparison by Drug Class (2026-2033)
1.3.2 Global Narcolepsy Therapeutics Market Revenue Market Share by Drug Class in 2025
1.3.3 Oxybates
1.3.4 Stimulants and Wakefulness-Promoting Agents
1.3.5 Orexin Receptor Agonists
1.3.6 Other Drug Classes
1.4 Global Narcolepsy Therapeutics Market by Disease Type
1.4.1 Global Narcolepsy Therapeutics Market Size and Market Share Comparison by Disease Type (2026-2033)
1.4.2 Narcolepsy Type 1
1.4.3 Narcolepsy Type 2
1.5 Classification of Narcolepsy Therapeutics Market by Distribution Channel
1.5.1 Global Narcolepsy Therapeutics Market Revenue Comparison by Distribution Channel (2026-2033)
1.5.2 Global Narcolepsy Therapeutics Market Revenue Market Share by Distribution Channel in 2025
1.5.3 Hospital Pharmacies
1.5.4 Retail Pharmacies
1.5.5 Online Pharmacies
1.6 Global Narcolepsy Therapeutics Market by Regions
1.6.1 Global Narcolepsy Therapeutics Market Size (USD Billion) Comparison by Regions (2026-2033)
1.6.2 North America (USA, Canada, and Mexico) Narcolepsy Therapeutics Market Status and Prospect (2021-2033)
1.6.3 Europe (Germany, France, UK, Italy, Spain, Rest of Europe) Narcolepsy Therapeutics Market Status and Prospect (2021-2033)
1.6.4 Asia Pacific (China, Japan, India, South Korea, Rest of Asia Pacific) Narcolepsy Therapeutics Market Status and Prospect (2021-2033)
1.6.5 Latin America (Brazil, Rest of Latin America) Narcolepsy Therapeutics Market Status and Prospect (2021-2033)
1.6.6 Middle East & Africa (GCC, South Africa, Rest of Middle East & Africa) Narcolepsy Therapeutics Market Status and Prospect (2021-2033)
1.7 Global Market Size of Narcolepsy Therapeutics Market (2021-2033)

Chapter 2: Market Dynamics

2.1 Market Drivers
2.2 Market Restraints
2.3 Value Chain Analysis
2.4 Market Opportunities
2.5 SWOT Analysis
2.5.1 Strengths
2.5.2 Weaknesses
2.5.3 Opportunities
2.5.4 Threats
2.6 Top Investment Pockets
2.7 Key Impacting Factor
2.8 Porter's Five Forces Analysis
2.8.1 Competitive Rivalry within the Industry
2.8.2 Threat of New Entrants
2.8.3 Bargaining Power of Suppliers
2.8.4 Bargaining Power of Buyers
2.8.5 Threat of Substitute Products or Services
2.9 Key Market Strategies
2.9.1 Key Market Strategies, 2025 (%)
2.10 PESTEL Analysis
2.10.1 Political Factors
2.10.2 Economic Factors
2.10.3 Social Factors
2.10.4 Technological Factors
2.10.5 Environmental Factors
2.10.6 Legal Factors
2.10.7 PESTEL Analysis

Chapter 3: Company Profiles

3.1 Jazz Pharmaceuticals plc
3.1.1 Company Basic Information and Its Competitors
3.1.2 Jazz Pharmaceuticals plc Product Category
3.1.3 Jazz Pharmaceuticals plc Narcolepsy Therapeutics Market Revenue (2023-2025)
3.1.4 Recent Developments
3.1.5 Main Business/Business Overview
3.2 Harmony Biosciences Holdings, Inc.
3.3 Avadel Pharmaceuticals plc
3.4 Takeda Pharmaceutical Company Limited
3.5 Teva Pharmaceutical Industries Ltd.
3.6 Axsome Therapeutics, Inc.
3.7 Alkermes plc
3.8 Zevra Therapeutics, Inc.
3.9 Amneal Pharmaceuticals, Inc.
3.10 Azurity Pharmaceuticals, Inc.
3.11 Novartis AG
3.12 Hikma Pharmaceuticals plc
3.13 Arena Pharmaceuticals, Inc. (Pfizer Inc.)
3.14 Prasco LLC
3.15 Sunovion Pharmaceuticals Inc. (Sumitomo Pharma)
3.16 Johnson & Johnson (Janssen Pharmaceuticals)
3.17 H. Lundbeck A/S
3.18 Lupin Limited
3.19 Torrent Pharmaceuticals Ltd.
3.20 Ligand Pharmaceuticals Incorporated
3.21 Roche Holding AG
3.22 Eli Lilly and Company
3.23 Rhodes Pharmaceuticals L.P. (Purdue Pharma)
3.24 NLS Pharmaceutics Ltd.
3.25 Suven Life Sciences Limited
3.26 XW Pharma (Xenon Pharma)
3.27 Balance Therapeutics, Inc.
3.28 Vanda Pharmaceuticals Inc.
3.29 Aerial BioPharma, LLC
3.30 Cerecor Inc. (Avalo Therapeutics)

Chapter 4: Global Narcolepsy Therapeutics Market Competition, by Players

4.1 Global Narcolepsy Therapeutics Market Revenue and Share by Players (2023-2025)
4.2 Player Positioning
4.3 Top 5 Narcolepsy Therapeutics Market Players Market Share Market Concentration Rate
4.3.1 Top 3 Narcolepsy Therapeutics Market Players Market Share
4.3.2 Top 5 Narcolepsy Therapeutics Market Players Market Share

Chapter 5: Global Narcolepsy Therapeutics Market Size by Regions

5.1 Global Narcolepsy Therapeutics Market Revenue, and Market Share by Regions
5.2 North America Narcolepsy Therapeutics Market Revenue, and Growth Rate (2021-2025)
5.3 Europe Narcolepsy Therapeutics Market Revenue, and Growth Rate (2021-2025)
5.4 Asia Pacific Narcolepsy Therapeutics Market Revenue, and Growth Rate (2021-2025)
5.5 Latin America Narcolepsy Therapeutics Market Revenue, and Growth Rate (2021-2025)
5.6 Middle East & Africa Narcolepsy Therapeutics Market Revenue, and Growth Rate (2021-2025)

Chapter 6: North America Narcolepsy Therapeutics Market Revenue by Countries

6.1 North America Narcolepsy Therapeutics Market Revenue, by Countries (2021-2025)
6.2 USA Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
6.3 Canada Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
6.4 Mexico Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
6.5 North America Narcolepsy Therapeutics Market Revenue and Market Share by Drug Class (2021-2025)
6.6 North America Narcolepsy Therapeutics Market Share by Disease Type (2021-2025)
6.7 North America Narcolepsy Therapeutics Market Share by Distribution Channel (2021-2025)

Chapter 7: Europe Narcolepsy Therapeutics Market Revenue by Countries

7.1 Europe Narcolepsy Therapeutics Market Revenue, by Countries (2021-2025)
7.2 Germany Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
7.3 France Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
7.4 UK Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
7.5 Italy Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
7.6 Spain Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
7.7 Rest of Europe Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
7.8 Europe Narcolepsy Therapeutics Market Revenue and Market Share by Drug Class (2021-2025)
7.9 Europe Narcolepsy Therapeutics Market Share by Disease Type (2021-2025)
7.10 Europe Narcolepsy Therapeutics Market Share by Distribution Channel (2021-2025)

Chapter 8: Asia Pacific Narcolepsy Therapeutics Market Revenue by Countries

8.1 Asia Pacific Narcolepsy Therapeutics Market Revenue, by Countries (2021-2025)
8.2 China Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
8.3 Japan Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
8.4 India Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
8.5 South Korea Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
8.6 Rest of Asia Pacific Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
8.7 Asia Pacific Narcolepsy Therapeutics Market Revenue and Market Share by Drug Class (2021-2025)
8.8 Asia Pacific Narcolepsy Therapeutics Market Share by Disease Type (2021-2025)
8.9 Asia Pacific Narcolepsy Therapeutics Market Share by Distribution Channel (2021-2025)

Chapter 9: Latin America Narcolepsy Therapeutics Market Revenue by Countries

9.1 Latin America Narcolepsy Therapeutics Market Revenue, by Countries (2021-2025)
9.2 Brazil Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
9.3 Rest of Latin America Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
9.4 Latin America Narcolepsy Therapeutics Market Revenue and Market Share by Drug Class (2021-2025)
9.5 Latin America Narcolepsy Therapeutics Market Share by Disease Type (2021-2025)
9.6 Latin America Narcolepsy Therapeutics Market Share by Distribution Channel (2021-2025)

Chapter 10: Middle East & Africa Narcolepsy Therapeutics Market Revenue by Countries

10.1 Middle East & Africa Narcolepsy Therapeutics Market Revenue by Countries (2021-2025)
10.2 GCC Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
10.3 South Africa Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
10.4 Rest of Middle East & Africa Narcolepsy Therapeutics Market Revenue and Growth Rate (2021-2025)
10.5 Middle East & Africa Narcolepsy Therapeutics Market Revenue and Market Share by Drug Class (2021-2025)
10.6 Middle East & Africa Narcolepsy Therapeutics Market Share by Disease Type (2021-2025)
10.7 Middle East & Africa Narcolepsy Therapeutics Market Share by Distribution Channel (2021-2025)

Chapter 11: Global Narcolepsy Therapeutics Market Segment by Drug Class

11.1 Global Narcolepsy Therapeutics Market Revenue and Market Share by Drug Class (2021-2025)
11.2 Oxybates
11.2.1 Global Oxybates Market Revenue by Regions (2021-2025)
11.3 Stimulants and Wakefulness-Promoting Agents
11.3.1 Global Stimulants and Wakefulness-Promoting Agents Market Revenue by Regions (2021-2025)
11.4 Orexin Receptor Agonists
11.4.1 Global Orexin Receptor Agonists Market Revenue by Regions (2021-2025)
11.5 Other Drug Classes
11.5.1 Global Other Drug Classes Market Revenue by Regions (2021-2025)
11.6 Global Narcolepsy Therapeutics Market Forecast by Drug Class (2026-2033)

Chapter 12: Global Narcolepsy Therapeutics Market Segment by Disease Type

12.1 Global Narcolepsy Therapeutics Market Share by Disease Type (2021-2025)
12.2 Narcolepsy Type 1
12.2.1 Global Narcolepsy Type 1 Market Revenue by Regions (2021-2025)
12.3 Narcolepsy Type 2
12.3.1 Global Narcolepsy Type 2 Market Revenue by Regions (2021-2025)
12.4 Narcolepsy Therapeutics Market Forecast by Disease Type (2026-2033)

Chapter 13: Global Narcolepsy Therapeutics Market Segment by Distribution Channel

13.1 Global Narcolepsy Therapeutics Market Revenue and Market Share by Distribution Channel (2021-2025)
13.2 Hospital Pharmacies
13.2.1 Global Hospital Pharmacies Market Revenue by Regions (2021-2025)
13.3 Retail Pharmacies
13.3.1 Global Retail Pharmacies Market Revenue by Regions (2021-2025)
13.4 Online Pharmacies
13.4.1 Global Online Pharmacies Market Revenue by Regions (2021-2025)
13.5 Narcolepsy Therapeutics Market Forecast by Distribution Channel (2026-2033)

Chapter 14: Global Narcolepsy Therapeutics Market Size Forecast (2026-2033)

14.1 Global Narcolepsy Therapeutics Market Size Forecast (2026-2033)
14.2 Global Narcolepsy Therapeutics Market Revenue Forecast by Regions (2026-2033)
14.3 North America Narcolepsy Therapeutics Market Revenue Forecast (2026-2033)
14.3.1 North America Market Revenue Forecast by Country (2026-2033)
14.3.2 North America Market Revenue Forecast by Drug Class (2026-2033)
14.3.3 North America Market Revenue Forecast by Disease Type (2026-2033)
14.3.4 North America Market Revenue Forecast by Distribution Channel (2026-2033)
14.4 Europe Narcolepsy Therapeutics Market Revenue Forecast (2026-2033)
14.4.1 Europe Market Revenue Forecast by Country (2026-2033)
14.4.2 Europe Market Revenue Forecast by Drug Class (2026-2033)
14.4.3 Europe Market Revenue Forecast by Disease Type (2026-2033)
14.4.4 Europe Market Revenue Forecast by Distribution Channel (2026-2033)
14.5 Asia Pacific Narcolepsy Therapeutics Market Revenue Forecast (2026-2033)
14.5.1 Asia Pacific Market Revenue Forecast by Country (2026-2033)
14.5.2 Asia Pacific Market Revenue Forecast by Drug Class (2026-2033)
14.5.3 Asia Pacific Market Revenue Forecast by Disease Type (2026-2033)
14.5.4 Asia Pacific Market Revenue Forecast by Distribution Channel (2026-2033)
14.6 Latin America Narcolepsy Therapeutics Market Revenue Forecast (2026-2033)
14.6.1 Latin America Market Revenue Forecast by Country (2026-2033)
14.6.2 Latin America Market Revenue Forecast by Drug Class (2026-2033)
14.6.3 Latin America Market Revenue Forecast by Disease Type (2026-2033)
14.6.4 Latin America Market Revenue Forecast by Distribution Channel (2026-2033)
14.7 Middle East & Africa Narcolepsy Therapeutics Market Revenue Forecast (2026-2033)
14.7.1 Middle East & Africa Market Revenue Forecast by Country (2026-2033)
14.7.2 Middle East & Africa Market Revenue Forecast by Drug Class (2026-2033)
14.7.3 Middle East & Africa Market Revenue Forecast by Disease Type (2026-2033)
14.7.4 Middle East & Africa Market Revenue Forecast by Distribution Channel (2026-2033)

Chapter 15: Premium Analyst Insights

15.1 Key Market Insights on Drug Class Segment
15.1.1 Fastest Growing Segment
15.1.2 Largest Segment
15.2 Key Market Insights on Disease Type Segment
15.2.1 Fastest Growing Segment
15.2.2 Largest Segment
15.3 Key Market Insights on Regional Overview
15.3.1 Fastest Growing Region
15.3.2 Largest Region
15.3.3 Fastest Growing Country
15.3.4 Largest Country
15.4 Competitive Intelligence

Chapter 16: Appendix

16.1 Research Process
16.2 Primary and Secondary Research
16.2.1 Primary Research
16.2.2 Secondary Research
16.3 Market Size Estimation
16.4 Assumptions & Exclusions
16.5 List of Tables
16.6 List of Figures
16.7 Disclaimer